Burleson & Co’s Opko Health OPK Stock Holding History

Burleson & Co’s Portfolio OPK Stock Details OPK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1	Closed	–	–	443
2021 Q4	$0	Hold	1	–	–	﹤0.01%	388
2021 Q3	$0	Hold	1	–	–	﹤0.01%	390
2021 Q2	$0	Buy	+1	New	+$4	﹤0.01%	390

Other funds holding OPK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Burleson & Co's OPK Position: Q1 2022 in Review

Burleson & Co sold out of Opko Health (OPK) in Q1 2022, closing a stake of 1 share.

Burleson & Co first reported a position in OPK in Q2 2021 and held it in 3 quarters. The position peaked at $0 in Q4 2021. 229 funds tracked by Wall St. Rank hold OPK as of Q1 2022.

Burleson & Co reported no remaining Opko Health position as of Q1 2022 after selling out during the quarter.
Burleson & Co sold 1 Opko Health share in Q1 2022.
Burleson & Co first reported a position in Opko Health in Q2 2021 and held it in 3 quarters.
Burleson & Co's Opko Health position peaked at $0 in Q4 2021.
229 funds tracked by Wall St. Rank held Opko Health as of Q1 2022.

Based on Burleson & Co's 13F filing for Q1 2022, filed 25 Apr 2022.